Key result
RT-RAP shows high agreement with commercial RT-PCR for detecting norovirus GII and group A rotavirus.
Why the study?
Rapid and sensitive detection methods are essential for the early diagnosis of diarrhea caused by norovirus and rotavirus.
Does RT-RAP improve the detection of norovirus GII and group A rotavirus in fecal specimens compared to commercial qRT-PCR?
Does RT-RAP improve the detection of norovirus GII and group A rotavirus in fecal specimens compared to commercial qRT-PCR?
Effect estimate: kappa 0.957 and 0.98
p-value: p=< 0.05
RT-RAP is a highly sensitive and rapid method for simultaneous detection of norovirus GII and group A rotavirus in clinical fecal specimens.
Supports RT-RAP evaluation for norovirus GII and RVA detection; leaves open routine adoption pending larger validation studies.
The most prevalent viruses currently causing diarrhea are norovirus and rotavirus, and rapid and sensitive detection methods are essential for the early diagnosis of disease. The purpose of this study was to establish a sensitive single-tube two-stage nucleic acid amplification method-reverse transcription recombinase-assisted PCR (RT-RAP)-for simultaneous detection of norovirus GII and group A Rotavirus, with the first stage consisting of isothermal reverse transcription recombinase-aided amplification (RT-RAA) and the second stage consisting of qPCR (quantitative PCR). RT-RAP is more sensitive than either RT-RAA or qRT-PCR (quantitative RT-PCR) alone. And the addition of a barrier that can be disassembled after heating enabled the detection of samples within 1 h in a single closed tube. Sensitivity was 10 copies/reaction of norovirus (Novs) GII and group A rotavirus (RVA). In parallel, two hundred fecal specimens were used to evaluate the method and compare it with a commercial fluorescent quantitative RT-PCR. The data showed kappa values of 0.957 and 0.98 (p < 0.05) for detecting Novs GII and RVA by the two methods, indicating the potential of the newly established assay to be applied to clinical and laboratory testing.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) studied Norovirus GII and group A rotavirus infection (n=200). Reverse transcription recombinase-assisted PCR (RT-RAP) vs. Commercial fluorescent quantitative RT-PCR was evaluated on Detection agreement (kappa value) for Novs GII and RVA (kappa 0.957 and 0.98, p=< 0.05). The RT-RAP assay demonstrated high agreement with commercial fluorescent quantitative RT-PCR for detecting norovirus GII and group A rotavirus, with kappa values of 0.957 and 0.98 (p < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: